Investigators and Program Directors

Select Publications

• Shixia Wang, Jeff Kennedy, Kim West, David C. Montefiori, Anju Bansal, Paul Goepfert, Scott Coley, John Lawrence, Siyuan Shen, Sharon Green, Alan Rothman, Frank Ennis, Ranajit Pal, Phillip Markham and Shan Lu. Balanced Cellular and antibody responses induced by the polyvalent DNA Prime-Protein Boost HIV-1 Vaccine formulation DP6-001 in healthy human volunteers. (in review)
• Frey, SF, Newman, FK, Kennedy, JS, Sobek, V, Ennis, FA, Hill, H, Yan, LK, Chaplin. P, Vollmar, J, Belshe, RB. Clinical and Immunologic Responses to Multiple Doses of IMVAMUNE® (Modified Vaccinia Ankara) Followed by Dryvax® Challenge. (in review).
• Sivapalasinggam, S, Kennedy, JS, Borkowsky, W, Valentine, F, Zhan, M-X, Pazoles, P, Paolino, A, Ennis, FA, Steigbigel, N. Immunological Memory following exposure to variola virus, monkeypox virus and vaccinia (Dryvax). J Infect Dis 2007; 195(8):1151-9.
• Terajima M, Cruz J, Leporati AM, Demkowicz WE Jr, Kennedy JS, Ennis FA. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class molecules, HLA-A2 or HLA-B7. Hum Immunol. 2006; 67(7):512-20.
• Monath, TP, Liu, J, Kanesa-Thasan, N, Myers, G, Nichols, R, Deary, A, McCarthy, K, Johnson, C, Ermak, T, Sunheang, S, Guirakhoo, F, Kennedy, JS, Ennis, FA, Green, S, Bedford, P. A live, attenuated vaccine against West Nile virus. PNAS 2006; 103(17): 6694-6699.
• Wood, SM, Kennedy JS, Arsenault, JE, Thomas, DL, Buck, RH, Shippee, RL, Demichele, SJ, Winship, TR, Schaller, JP, Montain, S, and Cordle, CT. Novel Nutritional Immune Formula Maintains Host Defense Mechanisms. Military Medicine 2005, 170(11): 975-985.
• Pal, R, Qiao, Y, Wang, S, Kalyanaraman, VS, Nair, BC, Whitney, S, Keen, T, Hung, C-L, Hocker, L, Hudacik, L, Kennedy, JS, Markham, P, Lu, S. Definitive toxicology and biodistribution study of a polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 (HIV-1) Vaccine in rabbits. Vaccine 2006; 24(8):1225-34.
• Kelso, JM, Kuhn, KM, Newman, FK, Kennedy, JS, Frey, SE. Immune status in a primary smallpox vaccinee who failed to develop an immunization site reaction. JAMA (Lett) 2005, 293(6):677-78.
• Mathew, A, West, K, Terajima, M, Green, S, Rothman, AL, Ennis, FA, and Kennedy, JS. Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles. J Immunol 2005, 174:2212-2219.
• Greenberg, RN, Kennedy, JS, Clanton, DJ, Plummer, EA, Hague, L, Cruz, J, Ennis, FA, Blackwelder, WC, and Hopkins, RJ. Evaluation of Safety and Immunogenicity of a New Cell-Cultured Smallpox Vaccine (CCSV) Compared with a Calf Lymph Derived Smallpox Vaccine (Dryvax®). Lancet 2005; 365: 398-409.
• Kennedy, JS., Frey, SE., Yan, L., Rothman, AL., Cruz, J., Newman, FK., Orphin, L., Belshe, RB., and Ennis, FA. Induction of Human T-Cell-mediated Immune Responses after Primary and Secondary Smallpox Vaccination. Journal of Infectious Disease 2004; 190(7):1286-94.
• Weltzin R., Liu, J., Pugachev, KV, Myers, G., Coughlin, B., Nichols, R., Johnson, C., Cruz, J., Kennedy, JS, Ennis, FA, Monath, TP. Clonal cell culture-grown vaccinia virus (New York City Board of Health strain) as a second-generation smallpox vaccine. Nature Medicine 2003; 9(9):1125-1130.
• Terajima, M., Cruz, JC, Raines, G., Kilpatrick, ED., Kennedy, JS, Rothman, AL., Ennis, FA. Quantitation of CD8+ T cell Responses to Newly Identified HLA-A*0201-restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses. J. Exp. Med. 2003; 197(7):927-932.
• Frey, SE, Newman, FK, Cruz, J, Shelton, B, Tennant, JM, Polach, T, Rothman, AL, Kennedy, JS, Wolff, M, Belshe, RB, Ennis, FA. Dose-related effects of smallpox vaccine. New England J Medicine 2002; 346(17):1275-80.

Contact Information

Phone: 518-473-8421
Fax: 518-473-2900
Email: jsk07@health.state.ny.us